studi
aim
evalu
antivir
role
nucleic
acidbas
agonist
activ
tolllik
receptor
tlr
signal
pathway
protect
role
respiratori
influenza
viru
infect
express
myeloid
dendrit
cell
respiratori
epithelium
macrophag
appear
play
central
role
mediat
antivir
inflammatori
respons
innat
immun
combat
viral
infect
influenza
virus
effect
inhibit
host
abil
produc
interferon
therebi
suppress
immun
system
antivir
defenc
mechan
poli
iclc
synthet
doubl
strand
rna
compris
polyriboinosinicpoli
ribocytidyl
acid
poli
ic
stabil
llysin
l
carboxymethylcellulos
c
poli
iclc
liposomeencapsul
poli
iclc
le
poli
iclc
agonist
potent
induc
interferon
natur
killer
cell
intranas
pretreat
mice
poli
iclc
le
poli
iclc
provid
high
level
protect
lethal
challeng
highli
lethal
avian
influenza
hpai
strain
clade
lethal
season
influenza
viru
strain
durat
protect
antivir
immun
multipl
lethal
dose
influenza
viru
viru
previous
found
persist
week
mice
le
poli
iclc
week
poli
iclc
similarli
pretreat
mice
cpg
oligonucleotid
agonist
also
found
provid
complet
protect
influenza
infect
mice
rtpcr
analysi
lung
tissu
mice
treat
poli
iclc
le
poli
iclc
reveal
upregul
mrna
gene
express
taken
togeth
result
support
potenti
role
agonist
poli
iclc
le
poli
iclc
protect
lethal
season
hpai
viru
infect
crown
innat
immun
system
play
central
role
detect
invad
viral
pathogen
respond
activ
inflammatori
antivir
defenc
mechan
combat
viral
agent
evad
defenc
machan
influenza
virus
known
circumv
potent
antivir
interferon
action
inhibit
interferon
regulatori
factor
gener
interferon
signal
pathway
virus
achiev
part
doubl
strand
rna
ds
rna
bind
protein
call
nonstructur
influenza
virus
replic
unab
host
respiratori
tract
influenza
viral
replic
singl
strand
ss
rna
ds
rna
intermedi
molecul
recogn
tolllik
receptor
tlr
express
cell
innat
immun
includ
dendrit
cell
natur
killer
cell
macrophag
well
respiratori
epithelium
elsewher
tolllik
receptor
transmembran
signal
protein
design
specif
recogn
variou
protein
carbohydr
lipid
nucleic
acid
invad
microorgan
activ
trigger
immun
inflammatori
respons
respond
infecti
agent
four
known
tolllik
receptor
found
mammalian
cell
recogn
nucleic
acid
found
endosom
membran
sinc
nucleic
acidrecogn
tlr
regul
induct
type
interferon
antivir
gene
function
rational
target
antivir
drug
develop
previou
studi
demonstr
contribut
immun
respons
respiratori
epitheli
cell
influenza
ds
rna
molecular
mechan
immun
enhanc
gener
believ
mediat
mitogenactiv
protein
kinas
phosphatidylinositol
signal
associ
adaptor
molecul
trif
paper
outlin
antivir
activ
two
tlr
agonist
examin
applic
induc
protect
antivir
immun
influenza
virus
includ
season
avian
strain
poli
iclc
synthet
ds
rna
condens
polyllysin
carboxymethylcellulos
known
agonist
xray
crystal
structur
poli
ic
receptor
signal
complex
determin
sinc
activ
ds
rna
result
induct
type
interferon
follow
poli
iclc
deliv
liposom
endosom
membran
locat
may
strengthen
host
antivir
defenc
influenza
viru
prime
interferon
level
therefor
revers
interferon
knockdown
virus
addit
oligonucleotid
contain
unmethyl
cpg
motif
agonist
evalu
stand
alon
immunomodul
antivir
agent
poli
iclc
oligonucleotid
contain
unmethyl
cpg
motif
use
studi
suppli
oncovir
inc
washington
dc
oligo
etc
inc
wilsonvil
respect
method
prepar
lipid
composit
liposomeencapsul
poli
iclc
previous
describ
primer
procur
appli
biosystem
abi
streetsvil
mice
pretreat
two
intranas
dose
poli
iclc
le
poli
iclc
mgkg
bodi
weight
sham
liposom
pb
given
h
apart
h
postdrug
treatment
mice
euthan
cervic
disloc
lung
asept
remov
homogen
trizol
total
rna
extract
lung
tissu
trizol
method
invitrogen
one
g
rna
use
dnase
fermenta
digest
rt
revers
transcript
make
strand
cdna
rt
perform
use
high
capac
cdna
rt
kit
random
primer
abi
thermal
profil
rt
step
follow
c
min
hold
c
min
hold
c
hold
realtim
pcr
perform
use
taqman
probebas
detect
abi
run
abi
fast
system
taqman
gene
express
assay
abi
consist
two
unlabel
pcr
primer
fam
dye
label
taqman
mgb
minor
groov
binder
probe
pcr
step
follow
c
enzym
activ
cycl
denatur
c
anneal
extens
c
use
intern
control
normal
express
target
gene
compar
ct
method
rel
quantit
use
calcul
fold
chang
serial
dilut
differ
input
target
refer
gene
perform
verifi
effici
target
refer
approxim
equal
data
shown
data
analysi
perform
use
softwar
abi
poli
iclc
cpg
oligonucleotid
cpg
odn
whether
unencapsul
encapsul
liposom
administ
intranas
g
bodi
weight
balbc
femal
mice
prophylaxi
influenza
viru
infect
group
mice
anim
per
group
given
two
dose
free
liposom
poli
iclc
mgkg
bodi
weight
h
apart
intranas
rout
volum
inoculum
use
l
variou
day
postdrug
treatment
mice
intranas
challeng
either
ld
influenza
ld
influenza
virus
anim
monitor
daili
symptom
infect
bodi
weight
surviv
day
postinfect
number
mice
surviv
viru
infect
group
record
surviv
pattern
control
treat
mice
graph
use
logrank
test
graphpad
prism
version
san
diego
ca
surviv
variou
test
group
compar
control
group
use
logrank
test
differ
consid
signific
p
effect
poli
iclc
le
poli
iclc
express
lung
mice
intranas
pretreat
drug
determin
rtpcr
fig
poli
iclc
le
poli
iclc
found
upregul
mrna
express
lung
tissu
fig
increas
express
detect
earli
h
postdrug
administr
still
pronounc
h
postdrug
administr
contrast
sham
liposom
empti
liposom
without
poli
iclc
effect
express
lung
magnitud
upregul
slightli
higher
poli
iclc
group
h
time
point
compar
le
poli
iclc
wherea
le
poli
iclc
upregul
higher
compar
poli
iclc
h
differ
poli
iclc
le
poli
iclc
express
signific
statist
similar
increas
express
also
observ
poli
iclc
le
poli
iclc
group
spleen
mice
increas
lower
magnitud
shorter
durat
compar
level
obtain
lung
data
shown
use
establish
lethal
influenza
infect
murin
model
previous
describ
protect
activ
poli
iclc
le
poli
iclc
variou
influenza
strain
determin
assess
surviv
rate
day
postinfect
ld
dose
influenza
virus
tabl
result
summar
show
poli
iclc
le
poli
iclc
highli
effect
protect
mice
season
avian
influenza
virus
tabl
pretreat
mice
poli
iclc
le
poli
iclc
found
efficaci
pretreat
exogen
administ
influenza
data
studi
suggest
prophylact
protect
provid
poli
iclc
le
poli
iclc
broadspectrum
effect
protect
strain
kg
bodi
weight
sham
liposom
pb
analyz
use
qrtpcr
describ
section
result
normal
endogen
control
shown
fold
increas
rel
pb
control
group
error
bar
repres
standard
error
mean
durat
protect
provid
poli
iclc
le
poli
iclc
previous
report
le
poli
iclc
provid
protect
ld
influenza
pretreat
given
day
prior
viru
challeng
comparison
pretreat
poli
iclc
protect
given
day
prior
viru
challeng
provid
protect
given
day
prior
viru
challeng
longer
durat
le
poli
iclc
compar
poli
iclc
assum
attribut
liposom
deliveri
gradual
releas
poli
iclc
liposom
remain
confirm
studi
evalu
efficaci
cpg
odn
influenza
mice
given
g
cpg
odn
day
prior
infect
lethal
dose
influenza
fig
use
model
mice
pretreat
cpg
odn
liposomeencapsul
cpg
odn
complet
protect
surviv
rate
day
postinfect
otherwis
lethal
viru
challeng
studi
carri
determin
whether
incorpor
cpg
odn
liposom
would
confer
longer
window
protect
compar
unencapsul
cpg
odn
result
present
affirm
antivir
role
nucleic
acidbas
tlr
agonist
poli
iclc
cpg
odn
broadspectrum
protect
variou
season
avian
influenza
virus
activ
tlr
signal
pathway
result
stimul
innat
adapt
immun
respons
may
partial
respons
antivir
state
influenza
infect
influenza
virus
highli
effect
adapt
infecti
agent
overcom
antivir
therapi
develop
drug
resist
overcom
host
immun
defenc
mechan
convent
antiinfluenza
drug
target
viru
structur
suscept
emerg
drug
resist
anim
studi
suggest
activ
tlr
signal
pathway
tlr
agonist
provid
protect
influenza
viru
infect
also
respiratori
syncyti
viru
sarscov
hepat
b
among
other
activ
tolllik
receptor
signal
pathway
may
repres
effect
broadspectrum
strategi
virus
approach
target
cell
innat
immun
system
henc
less
like
result
drug
resist
addit
provid
effect
mean
enhanc
andor
restor
interferon
product
viral
replic
summari
tlr
agonist
may
repres
affect
broadspectrum
antivir
strategi
combat
influenza
virus
unpredict
ever
chang
